{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:26:27Z","timestamp":1787840787089,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>A 70-year-old woman presented with a painless and rapidly enlarging mass on her right lower eyelid that had developed within the previous 3 weeks. The patient underwent surgical excision of the tumor, and based on the histopathological findings, the tumor was characterized as a high-grade neuroendocrine carcinoma with positive resection margins. However, immunopathological staining was positive for neuroendocrine markers, but negative for epithelial markers, which is not typical of Merkel cell carcinoma (MCC). Chemotherapy (Etoposide and Cisplatin, five cycles) was administered, and complete remission was achieved without further surgical excision. No evidence of tumor recurrence was observed at the 2-year follow-up. The findings in this case suggest that chemotherapy may be a potential treatment option for patients with large, advanced MCC of the eyelid.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-24-00008","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:00:38Z","timestamp":1774008038000},"page":"160-163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Complete remission of atypical Merkel cell carcinoma of eyelid with parotid gland and lymph node metastasis through chemotherapy"],"prefix":"10.4103","volume":"16","author":[{"given":"Pin-Chun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Shu","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Taiwan University Cancer Center, Taipei, Taiwan"},{"name":"Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woei-Yau","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology Oncology, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ya","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"R1-20260325","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.survophthal.2019.03.002","article-title":"Merkel cell carcinoma of the eyelid:A review","volume":"64","author":"North","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R2-20260325","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.2147\/OTT.S126640","article-title":"Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?","volume":"10","author":"Rabinowits","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R3-20260325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7181\/acfs.2018.02089","article-title":"Upper eyelid Merkel cell carcinoma treated with neoadjuvant chemotherapy and surgical excision","volume":"20","author":"Toto","year":"2019","journal-title":"Arch Craniofac Surg"},{"key":"R4-20260325","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ophtha.2007.02.024","article-title":"Merkel cell carcinoma of the eyelid review of the literature and report of patients with Merkel cell carcinoma showing spontaneous regression","volume":"115","author":"Missotten","year":"2008","journal-title":"Ophthalmology"},{"key":"R5-20260325","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0b013e3181b7f1d5","article-title":"Eyelid and periocular cutaneous Merkel cell carcinoma (aka. Neuroendocrine or trabecular carcinoma)","volume":"49","author":"Barrett","year":"2009","journal-title":"Int Ophthalmol Clin"},{"key":"R6-20260325","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/cancers6021128","article-title":"Merkel cell carcinoma of the eyelid and periocular region","volume":"6","author":"Merritt","year":"2014","journal-title":"Cancers (Basel)"},{"key":"R7-20260325","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients:The AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R8-20260325","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11154-017-9433-0","article-title":"Merkel cell carcinoma:Epidemiology, pathogenesis, diagnosis and therapy","volume":"18","author":"Amaral","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"R9-20260325","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1200\/JOP.2016.013367","article-title":"Recent insights and advances in the management of Merkel cell carcinoma","volume":"12","author":"Banks","year":"2016","journal-title":"J Oncol Pract"},{"key":"R10-20260325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.14240","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma:A 15-year institutional experience and statistical analysis of 721 reported cases","volume":"174","author":"Gunaratne","year":"2016","journal-title":"Br J Dermatol"},{"key":"R11-20260325","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/PAS.0000000000001136","article-title":"INSM1 is more sensitive and interpretable than conventional immunohistochemical stains used to diagnose Merkel cell carcinoma","volume":"42","author":"Lilo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R12-20260325","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00000478-199702000-00014","article-title":"Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites","volume":"21","author":"Chan","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R13-20260325","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/his.13758","article-title":"Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma","volume":"74","author":"Stanoszek","year":"2019","journal-title":"Histopathology"},{"key":"R14-20260325","first-page":"835","article-title":"Sentinel node status and immunosuppression:Recurrence factors in localized Merkel cell carcinoma","volume":"95","author":"Jouary","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R15-20260325","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2589::AID-CNCR15>3.0.CO;2-F","article-title":"Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma","volume":"85","author":"Voog","year":"1999","journal-title":"Cancer"},{"key":"R16-20260325","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2000.18.12.2493","article-title":"Chemotherapy in neuroendocrine\/Merkel cell carcinoma of the skin:Case series and review of 204 cases","volume":"18","author":"Tai","year":"2000","journal-title":"J Clin Oncol"},{"key":"R17-20260325","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"key":"R18-20260325","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/07357909109044222","article-title":"Chemotherapy of metastatic Merkel cell cancer","volume":"9","author":"Crown","year":"1991","journal-title":"Cancer Invest"},{"key":"R19-20260325","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/archsurg.134.4.388","article-title":"Multimodality management of Merkel cell carcinoma","volume":"134","author":"Ott","year":"1999","journal-title":"Arch Surg"},{"key":"R20-20260325","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","article-title":"Merkel cell carcinoma:Prognosis and treatment of patients from a single institution","volume":"23","author":"Allen","year":"2005","journal-title":"J Clin Oncol"},{"key":"R21-20260325","doi-asserted-by":"crossref","first-page":"djw042","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma:Survival analyses of 6908 cases from the national cancer data base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R22-20260325","doi-asserted-by":"crossref","first-page":"327150","DOI":"10.1155\/2013\/327150","article-title":"Merkel cell carcinoma:Chemotherapy and emerging new therapeutic options","volume":"2013","author":"Desch","year":"2013","journal-title":"J Skin Cancer"},{"key":"R23-20260325","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoto.2014.3052","article-title":"The role of adjuvant therapy in the management of head and neck Merkel cell carcinoma:An analysis of 4815 patients","volume":"141","author":"Chen","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:28:58Z","timestamp":1787837338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00008","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"2023-12-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}